The Prevalence of Asymptomatic Hyperuricemia in Patients with or Without Psoriatic Arthritis is Associated with a Similar Cardiovascular Risk

Gancheva, R.; Kundurzhiev, T.; Sheitanov, I.; Petranova, Tz.; Kolarov, Zl.; Yankova, P.; Nikolova, M.; Kundurdzhiev, A.

doi:10.2478/amb-2022-0024

References

1. Tripolino C, Ciaffi J, Ruscitti P et al. Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology and Clinical Implications. Front Med. 2021; 8:737573.
Search in Google Scholar Back to article
2. Lyngdoh T, Marques-Vidal P, Paccaud F et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One. 2011;6:e19901.
Search in Google Scholar Back to article
3. Ibrahim SE, Helmi A, Yousef TM et al. Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis. Egyptian Rheumatologist. 2012; 34:83-9. doi: 10.1016/j.ejr.2012.03.002.
Open DOI Search in Google Scholar Back to article
4. Gisondi P, Targher G, Cagalli A, Girolomoni G. Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2014;70:127-30.
Search in Google Scholar Back to article
5. Lai TL, Yim CW, Wong PY et al. Hyperuricemia in Asian psoriatic arthritis patients Int J Rheum Dis. 2018; 21(4):843-849.
Search in Google Scholar Back to article
6. Chu BBR, Chuha JPV, Marcon JMT. Does disease activity Influence the levels of Uric acid in Psoriatic Arthritis? The Open Rheumatology Journal. 2021; 15:57-64.
Search in Google Scholar Back to article
7. Goldman M. Uric acid in the etiology of psoriasis. Am J Dermatopathol. 1981; 3:397-404. doi: 10.1097/00000372-198100340-00014.
Open DOI Search in Google Scholar Back to article
8. Raucci F, Iqbal AJ, Saviano A et al. IL-17A neutralizing antibody regulates monosodium urate crystalinduced gouty inflammation. Pharmacol Res. 2019; 147:104351. doi: 10.1016/j.phrs.2019.104351.
Open DOI Search in Google Scholar Back to article
9. Klück V, Liu R, Joosten LAB. The role of interleukin-1 family members in hyperuricemia and gout. Joint Bone Spine. 2021; 88:105092. doi: 10.1016/j.jbspin.2020.105092.
Open DOI Search in Google Scholar Back to article
10. Chizyński K, Rózycka M. Hyperuricemia. Pol. Merkur. Lekarski (in Polish). 2005; 19 (113): 693-6. PMID 16498814.
Search in Google Scholar Back to article
11. Backhaus M, Burmester GR, Gerber T, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis. 2001; 60:641-9.
Search in Google Scholar Back to article
12. Beringer A, Miossec P. Systemic effects of IL-17 in inflammatory arthritis. Nat Rev Rheumatol. 2019; 15:491-501. doi: 10.1038/s41584-019-0243-5.
Open DOI Search in Google Scholar Back to article
13. Szendroedi J, Chmelik M, Schmid AI et al. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology. 2009; 50:1079-86. doi: 10.1002/hep.23093 54.
Open DOI Search in Google Scholar Back to article
14. Cortez-Pinto H, Chatham J, Chacko VP et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA. 1999; 282:1659-64. doi: 10.1001/jama.282.17.1659.
Open DOI Search in Google Scholar Back to article
15. Petrie JL, Patman GL, Sinha I et al. The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis. Am J Physiol Endocrinol Metab. 2013; 305:E1255-65. doi: 10.1152/ajpendo.00214.2013.
Open DOI Search in Google Scholar Back to article
16. Hosomi A, Nakanishi T, Fujita T, Tamai I. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. PLoS ONE. 2012; 7:e30456. doi: 10.1371/journal. pone.0030456.
Open DOI Search in Google Scholar Back to article
17. Fieldhouse KA, Ukaibe S, Crowley EL et al. Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors. Drugs Context. 2020 Apr 21; 9:2020-2-1.
Search in Google Scholar Back to article
18. Takada T, Ichida K, Matsuo H et al. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion. Nucleosides Nucleotides Nucleic Acids. 2014; 33:275-81. doi: 10.1080/15257770.2013.85490259.
Open DOI Search in Google Scholar Back to article
19. Englund G, Jacobson A, Rorsman F et al. Efflux transporters in ulcerative colitis: decreased expression of BCRP. (ABCG2) and Pgp. (ABCB1). Inflamm Bowel Dis. 2007; 13:291-7. doi: 10.1002/ibd.20030.
Open DOI Search in Google Scholar Back to article
20. Perez-Chada LM, Merola JF. Comorbidities associated with psoriatic arthritis: Review and update. Clin Immunol. 2020; 214:108397. doi: 10.1016/j.clim.2020.108397.
Open DOI Search in Google Scholar Back to article
21. Gong M, Wen S, Nguyen T et al. Converging relationships of obesity and hyperuricemia with special reference to metabolic disorders and plausible therapeutic implications. Diabetes Metab Syndr Obes. 2020; 13:943-62. doi: 10.2147/DMSO. S232377.
Open DOI Search in Google Scholar Back to article
22. Xu L, Shi Y, Zhuang S, Liu N. Recent advances on uric acid transporters. Oncotarget. 2017; 8:100852-62. doi: 10.18632/oncotarget.20135.
Open DOI Search in Google Scholar Back to article
23. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR et al. Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum. 2009; 39:157-62. doi: 10.1016/j.semarthrit.2008.06.001.
Open DOI Search in Google Scholar Back to article

The Prevalence of Asymptomatic Hyperuricemia in Patients with or Without Psoriatic Arthritis is Associated with a Similar Cardiovascular Risk

References

Paradigm

My account